QR-Code

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study

Abstract Ixekizumab (IXE), an IL-17 A inhibitor, demonstrated efficacy in clinical trials in patients with psoriatic arthritis (PsA), and favorable data have emerged from real-world evidence studies on psoriasis as well. However, real-world data specific to PsA remain limited. This study aims to ass...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Stefano Gentileschi, Riccardo Terribili, Carla Gaggiano, Elisa Fiorentini, Laura Cometi, Cosimo Cigolini, Fabio Massimo Perrotta, Silvia Scriffignano, Luca Di Cato, Anna Panaccione, Laura Niccoli, Fabrizio Cantini, Maurizio Benucci, Francesca Li Gobbi, Andrea Delle Sedie, Antonio Vitale, Ennio Lubrano, Bruno Frediani, Serena Guiducci
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Portfolio 2026-02-01
Schriftenreihe:Scientific Reports
Schlagworte:
Psoriatic arthritis
Ixekizumab
Interleukin-17
Real-world evidence
Online-Zugang:https://doi.org/10.1038/s41598-026-37835-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge